A fundamental challenge for cystic fibrosis (CF) gene therapy is ensuring sufficient transduction of airway epithelial cells to achieve therapeutic correction. Gene editing is a method to permanently ...
Researchers have demonstrated that lipid nanoparticles can package and deliver an entire therapeutic gene along with gene-editing machinery - a combination of large, complex components that non-viral ...
Co‑injecting three common amino acids with LNPs dramatically boosted both mRNA delivery and CRISPR gene editing efficiency in ...
Collaboration combines Intellia’s leading CRISPR-based platform, including its DNA writing technology, with ReCode’s proprietary Selective Organ Targeting (SORT) lipid nanoparticle (LNP) to extend the ...
Simple ‘cocktail’ of amino acids dramatically boosts power of mRNA therapies and CRISPR gene editing
Lipid nanoparticles, or LNPs, are best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results